Table 4.

Results of the probabilistic sensitivity analysis (Monte Carlo Simulation)

Probabilistic Sensitivity Analysis	Comparators	Mean Cost Per Patient (€)	Standard Deviation (SD)	Incremental Cost (€)*
ILI patients prior to hospitalisation, one half followed by intake of NI	Sofia® as an add-on	56.65	17.28	0
	Conventional approach	176.54	22.48	119.89

^*Incremental cost denotes the increase in total costs resulting from using the conventional approach alone versus including rapid testing.